loader
Please Wait
Applying Filters...

Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Cibinetide, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Cibinetide

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass

    Bora Pharmaceuticals- Making success more certain.

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    2D Structure
    1. Also known as: Phbsp, Ph-bsp, Ara290, Ara-290, 1208243-50-8, Ara 290
    Molecular Formula
    C51H84N16O21
    Molecular Weight
    1257.3  g/mol
    InChI Key
    WZTIQQBMSJTRBR-WYKNNRPVSA-N
    FDA UNII
    9W5677JKDA
    Cibinetide has been used in trials studying the basic science of Depression.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (4S)-5-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(1S)-1-carboxy-2-hydroxyethyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-oxo-4-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]pentanoic acid
    2.1.2 InChI
    InChI=1S/C51H84N16O21/c1-22(2)17-30(47(84)65-32(19-36(53)71)48(85)66-33(20-68)49(86)67-34(21-69)50(87)88)63-40(77)24(5)57-41(78)25(7-6-16-56-51(54)55)59-43(80)29(11-15-39(75)76)62-46(83)31(18-23(3)4)64-45(82)27(8-12-35(52)70)60-44(81)28(10-14-38(73)74)61-42(79)26-9-13-37(72)58-26/h22-34,68-69H,6-21H2,1-5H3,(H2,52,70)(H2,53,71)(H,57,78)(H,58,72)(H,59,80)(H,60,81)(H,61,79)(H,62,83)(H,63,77)(H,64,82)(H,65,84)(H,66,85)(H,67,86)(H,73,74)(H,75,76)(H,87,88)(H4,54,55,56)/t24-,25-,26-,27-,28-,29-,30-,31-,32-,33-,34-/m0/s1
    2.1.3 InChI Key
    WZTIQQBMSJTRBR-WYKNNRPVSA-N
    2.1.4 Canonical SMILES
    CC(C)CC(C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CO)C(=O)O)NC(=O)C(C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C1CCC(=O)N1
    2.1.5 Isomeric SMILES
    C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCC(=O)N1
    2.2 Other Identifiers
    2.2.1 UNII
    9W5677JKDA
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Ara-290

    2. Ara290

    3. Pglu-glu-gln-leu-glu-arg-ala-leu-asn-ser-ser

    4. Phbsp Peptide

    5. Pyroglutamate Helix B Surface Peptide

    6. Pyroglutamate-glutamyl-glutaminyl-leucyl-glutamyl-arginyl-alanyl-leucyl-asparagyl-seryl-serine

    7. Ueqleralnss

    2.3.2 Depositor-Supplied Synonyms

    1. Phbsp

    2. Ph-bsp

    3. Ara290

    4. Ara-290

    5. 1208243-50-8

    6. Ara 290

    7. Cibinetide [usan]

    8. Pglu-glu-gln-leu-glu-arg-ala-leu-asn-ser-ser

    9. 9w5677jkda

    10. Pyr-glu-gln-leu-glu-arg-ala-leu-asn-ser-ser-oh

    11. L-pyroglutamyl-l-glutamyl-l-glutaminyl-l-ieucyl-l-glutamyl-l-arginyl-l-alanyl-l-leucyl-l-asparaginyl-l-seryl-l-serine

    12. L-pyroglutamyl-l-glutamyl-l-glutaminyl-l-leucyl-l-glutamyl-l-arginyl-l-alanyl-l-leucyl-l-asparaginyl-l-seryl-l-serine

    13. Phbsp Peptide

    14. Unii-9w5677jkda

    15. Cibinetidecibinetide

    16. Pyroglutamate Helix B Surface Peptide

    17. Cibinetide [inn]

    18. Cibinetide (usan/inn)

    19. Cibinetide [who-dd]

    20. Gtpl9677

    21. Chembl3545305

    22. Ex-a6264

    23. Db13006

    24. Pyroglutamate-glutamyl-glutaminyl-leucyl-glutamyl-arginyl-alanyl-leucyl-asparagyl-seryl-serine

    25. L-serine, 5-oxo-l-prolyl-l-alpha-glutamyl-l-glutaminyl-l-leucyl-l-alpha-glutamyl-l-arginyl-l-alanyl-l-leucyl-l-asparaginyl-l-seryl-

    26. D11218

    27. Q27273306

    28. L-pyr-l-glu-l-gln-l-leu-l-glu-l-arg-l-ala-l-leu-l-asn-l-ser-l-ser

    29. L-serine, 5-oxo-l-prolyl-l-.alpha.-glutamyl-l-glutaminyl-l-leucyl-l-.alpha.-glutamyl-l-arginyl-l-alanyl-l-leucyl-l-asparaginyl-l-seryl-

    2.4 Create Date
    2015-07-11
    3 Chemical and Physical Properties
    Molecular Weight 1257.3 g/mol
    Molecular Formula C51H84N16O21
    XLogP3-7.7
    Hydrogen Bond Donor Count20
    Hydrogen Bond Acceptor Count22
    Rotatable Bond Count42
    Exact Mass1256.59969375 g/mol
    Monoisotopic Mass1256.59969375 g/mol
    Topological Polar Surface Area623 Ų
    Heavy Atom Count88
    Formal Charge0
    Complexity2560
    Isotope Atom Count0
    Defined Atom Stereocenter Count11
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Treatment of sarcoidosis

    Post Enquiry
    POST ENQUIRY